Covered recipient · General Payments record
DAVID JAMES KURTYKA
Allopathic & Osteopathic Physicians Dermatology MOHS-Micrographic Surgery
General Payments · PY2022–2024
$1,350.44
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $676.36 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $147.54 | 2 |
| UCB, Inc. | $145.87 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $140.95 | 3 |
| Regeneron Healthcare Solutions, Inc. | $121.07 | 1 |
| Janssen Biotech, Inc. | $120.93 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $3.78 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104121130 | CMS |
| ABBVIE INC. | $143.76 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104121132 | CMS |
| Janssen Biotech, Inc. | $25.49 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078607561 | CMS |
| Janssen Biotech, Inc. | $95.44 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078607981 | CMS |
| Novartis Pharmaceuticals Corporation | $70.27 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087108726 | CMS |
| Novartis Pharmaceuticals Corporation | $53.23 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087108728 | CMS |
| Novartis Pharmaceuticals Corporation | $17.45 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087108730 | CMS |
| Regeneron Healthcare Solutions, Inc. | $121.07 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114093827 | CMS |
| UCB, Inc. | $23.80 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143113529 | CMS |
| UCB, Inc. | $122.07 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143113531 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.